Bafna Pharma.

{
  "main_header": {
    "sid": 852453,
    "name": "Bafna Pharma.",
    "stock_name": "Bafna Pharma.",
    "full_name": "Bafna Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/bafna-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "243.01",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "243.01",
    "mcapval": "",
    "mcap": "Micro Cap",
    "scripcode": 532989,
    "symbol": "BAFNAPH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE878I01022",
    "curr_date": "Jul 23, 03:30 PM",
    "curr_time": "13:03 PM",
    "last_traded_at": "Jul 23, 03:30 PM IST",
    "bse_nse_vol": "8.38 k",
    "exc_status": "Active",
    "traded_date": "Jul 23, 2026",
    "traded_date_str": "2026 07 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 242.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2424-4117791",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_priceRelatedfactors_4117791.png",
        "date": "2026-07-23 10:44:59",
        "description": "Surging to a new 52-week high of Rs 242.4 on 23 Jul 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 170.84% gain over the past year against the Sensex's decline of 7.33%."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 237.65 on Back of Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs23765-4115244",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_priceRelatedfactors_4115244.png",
        "date": "2026-07-22 10:38:51",
        "description": "From a 52-week low of Rs 77.01 to a fresh peak of Rs 237.65, Bafna Pharmaceuticals Ltd has surged an impressive 162.8% over the past year, defying the broader market's downward trend. This remarkable rally culminated on 22 Jul 2026, when the stock touched its all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4107107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_mojoScore_4107107.png",
        "date": "2026-07-18 10:10:06",
        "description": "Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bafna Pharmaceuticals Gains 5.88%: 6 Key Factors Driving the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-588-6-key-factors-driving-the-rally-4088812",
        "imagepath": "",
        "date": "2026-07-04 15:03:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Jun:</strong> Upper circuit hit at Rs.204.00 amid strong buying pressure</p>\n                    <p><strong>30 Jun:</strong> New 52-week high at Rs.218.7 and upper circuit at Rs.214.63</p>\n                    <p><strong>1 Jul:</strong> New 52-week high at Rs.229.6 and upper circuit at Rs.225.36</p>\n                    <p><strong>2 Jul:</strong> New 52-week high at Rs.234.15</p>\n                    <p><strong>3 Jul:</strong> Week closes at Rs.220.55 (-2.00% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.208.30</div></div>\n                    <..."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4088424",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_mojoScore_4088424.png",
        "date": "2026-07-04 10:10:04",
        "description": "Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 234.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs23415-4084884",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_priceRelatedfactors_4084884.png",
        "date": "2026-07-02 10:36:27",
        "description": "Surging to a new 52-week and all-time high of Rs 234.15 on 2 Jul 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a sustained rally that has extended over nine consecutive trading sessions."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-surges-5-amid-strong-buying-pressure-4081378",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_stocks_hitting_upper_circuit_4081378.png",
        "date": "2026-07-01 10:00:20",
        "description": "At Rs 225.36, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 30 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 229.6",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs2296-4081226",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BafnaPharmaceut_priceRelatedfactors_4081226.png",
        "date": "2026-07-01 09:51:17",
        "description": "Surging to an intraday peak of Rs 229.6 on 1 Jul 2026, Bafna Pharmaceuticals Ltd has marked a significant milestone by reaching a fresh 52-week high. This rally, driven by a powerful alignment of technical indicators and sustained price momentum, underscores the stock’s robust upward trajectory over the past year."
      },
      {
        "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-4078567",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BafnaPharmaceut_stocks_hitting_upper_circuit_4078567.png",
        "date": "2026-06-30 10:00:17",
        "description": "At Rs 214.63, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 30 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      }
    ],
    "total": 353,
    "sid": "852453",
    "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453"
  },
  "announcements": [
    {
      "details": "Bafna Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Bafna Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": " <table><tr><td>The Exchange had sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>",
      "source": "NSE",
      "caption": "Reply to Clarification- Financial results",
      "datetime": "27-Aug-2019"
    },
    {
      "details": " <table><tr><td>BAFNAPHARM: Members of the Exchange are hereby informed that the trading in Equity Shares of Bafna Pharmaceuticals Limited shall be suspended w.e.f. August 26, 2019 (i.e. closing hours of trading on August 23, 2019) on account of Reduction of Share Capital. </td></tr></table>",
      "source": "NSE",
      "caption": "Suspension of trading in equity shares",
      "datetime": "21-Aug-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13",
          "dt": "2013-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 242.4

2026-07-23 10:44:59

Surging to a new 52-week high of Rs 242.4 on 23 Jul 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 170.84% gain over the past year against the Sensex's decline of 7.33%.

Read full news article

Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 237.65 on Back of Strong Technical Signals

2026-07-22 10:38:51

From a 52-week low of Rs 77.01 to a fresh peak of Rs 237.65, Bafna Pharmaceuticals Ltd has surged an impressive 162.8% over the past year, defying the broader market's downward trend. This remarkable rally culminated on 22 Jul 2026, when the stock touched its all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum.

Read full news article

Bafna Pharmaceuticals Ltd is Rated Sell

2026-07-18 10:10:06

Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bafna Pharmaceuticals Gains 5.88%: 6 Key Factors Driving the Rally

2026-07-04 15:03:03

Key Events This Week

29 Jun: Upper circuit hit at Rs.204.00 amid strong buying pressure

30 Jun: New 52-week high at Rs.218.7 and upper circuit at Rs.214.63

1 Jul: New 52-week high at Rs.229.6 and upper circuit at Rs.225.36

2 Jul: New 52-week high at Rs.234.15

3 Jul: Week closes at Rs.220.55 (-2.00% on day)

Week Open

Rs.208.30

<...

Read full news article

Bafna Pharmaceuticals Ltd is Rated Sell

2026-07-04 10:10:04

Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 234.15

2026-07-02 10:36:27

Surging to a new 52-week and all-time high of Rs 234.15 on 2 Jul 2026, Bafna Pharmaceuticals Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a sustained rally that has extended over nine consecutive trading sessions.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

2026-07-01 10:00:20

At Rs 225.36, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 30 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 229.6

2026-07-01 09:51:17

Surging to an intraday peak of Rs 229.6 on 1 Jul 2026, Bafna Pharmaceuticals Ltd has marked a significant milestone by reaching a fresh 52-week high. This rally, driven by a powerful alignment of technical indicators and sustained price momentum, underscores the stock’s robust upward trajectory over the past year.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

2026-06-30 10:00:17

At Rs 214.63, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 5.0% on 30 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

View All News